With more than 6,000 rare diseases identified around the world, there is a large degree of unmet need. Advanced Clinical has cultivated an extensive resume in partnering on the end-to-end development of new treatments for these conditions. We understand the complexities and the risks, and we also understand the need for patient centricity in these highly specialized studies. Explore our rare disease expertise in more detail in our fact sheet.
Providing for Patients
With rare disease research, preparing strategies that work for patients is a necessity, which is why we:
- Perform a robust feasibility assessment
- Plan for patients, families and caregivers
- Find new ways to engage with patients
- Increase awareness through existing relationships
- Offer mobile, at-home and local support
Locating the Right Site
We understand the need to find and activate a site quickly, and we use an array of advanced tools and our network of experts to ensure your research is up and running on time.
Mitigating Risk
We put our years of expertise to work ensuring risk mitigation is part of your study from the start with proactive planning and proven identification procedures.
Our Rare Disease Track Record
We’ve built a comprehensive knowledge base and have the practical know-how to maximize its use. Our expert solutions for rare disease clinical research are based on:
- 85 Phase I-IV studies
- Knowledgeable functional teams
- Experience coordinating all stakeholder and participant groups
Expertise From Across the World
Clinical research is difficult in even the most common areas, but the complexity of rare disease trials can make it feel insurmountable. With Advanced Clinical, you get experience from studies in more than 50 countries. Our support guides you over the hurdles while ensuring you keep to your timeline and budget while staying compliant.
Learn more about how our team of experts can help optimize and accelerate your rare disease drug development.
